PCRX PACIRA BIOSCIENCES INC
FollowStock (common), issuer CIK 1396814
Filings received so far for Q3 2026: 6 13F filers report a position in PCRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| RIKER LAURENofficer (Senior Vice President, Finance) | 2026-10-08 | -6,000 S | $36.32 | Form 4 |
| RIKER LAURENofficer (Senior Vice President, Finance) | 2026-10-08 | +6,000 M | $32.35 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 2,467 | $61.8K | <0.01% | +96 | 13F-HRTimeline |
| Versant Capital Management, Inc | 1,036 | $26K | <0.01% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 357 | $8.94K | <0.01% | +112 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 307 | $7.69K | <0.01% | -28 | 13F-HRTimeline |
| GILPIN WEALTH MANAGEMENT, LLC | 9 | $226 | <0.01% | 0 | 13F-HRTimeline |
| Davis Capital Management | 2 | $50 | <0.01% | 0 | 13F-HRTimeline |
Events
RIKER LAUREN reported transactions in PCRX shares with no net change in a Form 4 filed 2026-10-09. 0001628280-26-065566
Accepted , ingested